The best indicator for Salesforce (CRM)
We backtested 20 indicators across daily, weekly and hourly charts on real Salesforce (CRM) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
Bollinger Mean-Reversion
On the daily chart, this is the strongest risk-adjusted edge we found for Salesforce (CRM) over ~21.9 years — trailing buy-and-hold by 7.9% CAGR.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | Bollinger Mean-Reversion ✓ | Daily | 10.9% | 0.58 | -47.7% | 71.9% | 89 | -7.9% |
| 2 | Money Flow Index ✓ | Daily | 11.9% | 0.53 | -46.6% | 80.8% | 26 | -6.9% |
| 3 | Rate of Change ✓ | Weekly | 11.5% | 0.53 | -52.7% | 55.6% | 63 | -7.7% |
| 4 | SMA 50/200 Cross ✓ | Daily | 11.8% | 0.51 | -42.1% | 66.7% | 15 | -7.0% |
| 5 | CCI ✓ | Weekly | 9.3% | 0.51 | -50.4% | 81.8% | 22 | -9.9% |
| 6 | Donchian Midline ✓ | Weekly | 10.9% | 0.5 | -40.5% | 52.5% | 61 | -8.3% |
| 7 | WaveTrend (8/6/4) ✓ | Daily | 10.4% | 0.48 | -68.8% | 72.2% | 90 | -8.4% |
| 8 | EMA-10 Trend ✓ | Daily | 10.0% | 0.48 | -64.7% | 43.9% | 485 | -8.8% |
| 9 | RSI Trend (>50) ✓ | Daily | 9.8% | 0.47 | -51.6% | 40.1% | 284 | -9.0% |
| 10 | EMA 50/200 Cross ✓ | Daily | 13.0% | 0.54 | -41.6% | 61.5% | 13 | -5.8% |
| 11 | Donchian Breakout ✓ | Weekly | 9.1% | 0.46 | -47.2% | 68.4% | 19 | -10.0% |
| 12 | EMA 20/50 Cross ✓ | Daily | 9.2% | 0.45 | -42.6% | 46.0% | 50 | -9.6% |
| 13 | RSI Trend (>50) ✓ | Weekly | 9.3% | 0.45 | -40.7% | 51.5% | 68 | -9.9% |
| 14 | MACD ✓ | Weekly | 8.5% | 0.44 | -49.9% | 56.2% | 48 | -10.7% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Salesforce (CRM), Bollinger Mean-Reversion on the daily timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.